Embla Medical Sustainability Profile
Embla Medical, a leading name in the medical technology sector, is headquartered in Iceland (IS) and operates extensively across Europe and North America. Founded in 1998, the company has established itself as a pioneer in sleep diagnostics and respiratory care, offering innovative solutions that enhance patient outcomes. Embla Medical's core products include advanced sleep monitoring devices and software, which are distinguished by their accuracy and user-friendly design. The company has achieved significant milestones, including the development of cutting-edge polysomnography systems that cater to both clinical and home settings. With a strong market position, Embla Medical is recognised for its commitment to quality and innovation, making it a trusted partner for healthcare professionals worldwide.
DitchCarbon Score
How does Embla Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Embla Medical's score of 48 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Embla Medical's reported carbon emissions
Embla Medical hf, headquartered in Iceland, has set ambitious climate commitments to address its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established significant reduction targets. Embla Medical is committed to achieving net-zero greenhouse gas emissions across its value chain by 2050. For near-term goals, Embla Medical aims to reduce absolute Scope 1 and 2 greenhouse gas emissions by 79% by 2030, using 2019 as the baseline year. Additionally, the company plans to cut absolute Scope 3 emissions by 25% by 2030, with a baseline year of 2021. Looking further ahead, Embla Medical has set a long-term target to reduce absolute Scope 1 and 2 emissions by 90% by 2050, and Scope 3 emissions by 90% by 2050 as well. These targets align with the Science Based Targets initiative (SBTi) and are classified under the 1.5°C pathway, demonstrating Embla Medical's commitment to climate action in the healthcare equipment and supplies sector.
How Carbon Intensive is Embla Medical's Industry?
How Carbon Intensive is Embla Medical's Location?
Embla Medical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Embla Medical has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
